W. Faraj, A. Zaghal, O. El-beyrouthy, and A. Kutoubi, Complete catheter disconnection and migration of an implantable venous access device: the disconnected cap sign, Ann Vasc Surg, vol.24, issue.692, pp.11-16, 2010.

D. G. Maki, D. M. Kluger, and C. J. Crnich, The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies, Mayo Clin Proc, vol.81, pp.1159-71, 2006.

B. Yildizeli, T. Lacin, H. F. Batirel, and M. Yuksel, Complications and management of long-term central venous access catheters and ports, J Vasc Access, vol.5, pp.174-182, 2004.

A. Hartkamp, A. Boxtel, A. J. Zonnenberg, B. A. Witteveen, and P. O. , Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems, Neth J Med, vol.57, pp.215-238, 2000.

B. Sousa, J. Furlanetto, and M. Hutka, Central venous access in oncology: ESMO clinical practice guidelines, Ann Oncol, vol.26, pp.152-68, 2015.

N. Y. Ozdemir, H. Abali, B. Oksuzoglu, B. Budakoglu, I. Akmangit et al., It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting, Support Care Cancer, vol.17, pp.399-403, 2009.

H. Karanlik, H. Odabas, and I. Yildirim, Is there any effect of first-day usage of a totally implantable venous access device on complications?, Int J Clin Oncol, vol.20, pp.1057-62, 2015.

F. Narducci, M. Jean-laurent, and L. Boulanger, Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre, Eur J Surg Oncol, vol.37, pp.913-921, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00732666

R. J. Pratt, C. M. Pellowe, and J. A. Wilson, epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England, J Hosp Infect, vol.65, pp.1-64, 2007.

S. I. Seldinger, Catheter replacement of the needle in percutaneous arteriography; a new technique, Acta Radiol, vol.39, pp.368-76, 1953.

A. Zaghal, M. Khalife, and D. Mukherji, Update on totally implantable venous access devices, Surg Oncol, vol.21, pp.207-222, 2012.

A. Ignatov, O. Hoffman, and B. Smith, An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction, Eur J Surg Oncol, vol.35, pp.241-247, 2009.

L. Ji, J. Yang, J. Miao, Q. Shao, Y. Cao et al., Infections related to totally implantable venous-access ports: long-term experience in one center, Cell Biochem Biophys, vol.72, pp.235-275, 2015.

J. P. Seok, Y. J. Kim, H. M. Cho, H. Y. Ryu, W. J. Hwang et al., A retrospective clinical study: complications of totally implanted central venous access ports, Korean J Thorac Cardiovasc Surg, vol.47, pp.26-31, 2014.

D. Biacchi, P. Sammartino, and S. Sibio, Does the implantation technique for totally implantable venous access ports (TIVAPs) influence long-term outcome?, World J Surg, vol.40, pp.284-90, 2016.

R. Biffi, F. De-braud, and F. Orsi, Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days, Ann Oncol, vol.9, pp.767-73, 1998.

C. Araujo, J. P. Silva, and J. P. Antunes, A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients, Eur J Surg Oncol, vol.34, pp.222-228, 2008.